Measles-containing-vaccine second-dose (MCV2) immunization coverage in Albania
Albania: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 88.0% in 2025. ▲ Rising
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Albania, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Albania stood at 88.0%.
Compared with earlier readings it is down 4.3% on the previous year and down 10.2% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Albania peaked at 99.0% in 2011 and was at its lowest, 0.0%, in 2000.
That places Albania 76th out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 26 years of available data.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Albania, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 90.0% | — |
| 2002 | 93.0% | +3.3% |
| 2003 | 93.0% | +0.0% |
| 2004 | 96.0% | +3.2% |
| 2005 | 97.0% | +1.0% |
| 2006 | 94.0% | -3.1% |
| 2007 | 95.0% | +1.1% |
| 2008 | 98.0% | +3.2% |
| 2009 | 98.0% | +0.0% |
| 2010 | 98.0% | +0.0% |
| 2011 | 99.0% | +1.0% |
| 2012 | 99.0% | +0.0% |
| 2013 | 99.0% | +0.0% |
| 2014 | 98.0% | -1.0% |
| 2015 | 98.0% | +0.0% |
| 2016 | 98.0% | +0.0% |
| 2017 | 98.0% | +0.0% |
| 2018 | 96.0% | -2.0% |
| 2019 | 96.0% | +0.0% |
| 2020 | 94.0% | -2.1% |
| 2021 | 92.0% | -2.1% |
| 2022 | 93.0% | +1.1% |
| 2023 | 93.0% | +0.0% |
| 2024 | 92.0% | -1.1% |
| 2025 | 88.0% | -4.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 85.4% | 0.0% | 98.0% | 10 |
| 2010s | 97.9% | 96.0% | 99.0% | 10 |
| 2020s | 92.0% | 88.0% | 94.0% | 6 |
Countries ranked near Albania
More health data for Albania
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.287 % change on previous year (2090)
- Heat deaths vs projected death rates 2,085 (2090)
- Un projection of annual infant deaths 12 (2100)
- Population ages 65 and above, female, annual growth rate 3.07 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.0939 units per person (2025)
- Population ages 65 and above, male, annual growth rate 2.77 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.0823 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Albania?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Albania was 88.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Albania?
- The highest recorded value was 99.0% in 2011.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Albania?
- The lowest recorded value was 0.0% in 2000.
- How does Albania rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Albania ranks 76th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Albania?
- Over the last ten years it is down 10.2%. The long-run trend across the full record is rising.
- Where does this Albania data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).